n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with endothelin-1 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kita, T; Nakashima, T; Shimada, K; Suzumura, A; Takayanagi, T; Yonetani, Y | 2 |
Bagnato, A; Di Castro, V; Natali, PG; Nicotra, MR; RosanĂ², L; Spinella, F | 1 |
Fukai, N; Hirata, Y; Ozawa, N; Sato, R; Shichiri, M; Sugiyama, T; Yoshimoto, T | 1 |
Ge, Y; Kohan, DE; Strait, KA; Stricklett, PK; Yang, T | 1 |
Cai, Y; Chen, S; Feng, X; Gao, S; Huang, X; Li, H; Li, Q; Liu, P; Liu, Z; Lu, J; Ye, J | 1 |
6 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and endothelin-1
Article | Year |
---|---|
Cyclooxygenase 2 expression by endothelin-1-stimulated mouse resident peritoneal macrophages in vitro.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Indomethacin; Isoenzymes; Macrophages, Peritoneal; Mice; Nitrobenzenes; Oligopeptides; Peptides, Cyclic; Piperidines; Prostaglandin-Endoperoxide Synthases; Sulfonamides | 1998 |
Modulation by endothelin-1 of lipopolysaccharide-induced cyclooxygenase 2 expression in mouse peritoneal macrophages.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelin Receptor Antagonists; Endothelin-1; Isoenzymes; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Nitrobenzenes; Oligopeptides; Piperidines; Prostaglandin-Endoperoxide Synthases; Receptor, Endothelin B; Receptors, Endothelin; Sulfonamides; Vasoconstrictor Agents | 1999 |
Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Topics: Animals; Atrasentan; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelin A Receptor Antagonists; Endothelin-1; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Indomethacin; Isoenzymes; Luciferases; MAP Kinase Signaling System; Membrane Proteins; Mice; Mice, Nude; Nitrobenzenes; Ovarian Neoplasms; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrrolidines; Receptor, Endothelin A; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Transfection; Up-Regulation; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2004 |
Endothelin-1 induces cyclooxygenase-2 expression and generation of reactive oxygen species in endothelial cells.
Topics: Aldosterone; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endothelial Cells; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Induction; Flavonoids; Indoles; Male; Maleimides; Mitogen-Activated Protein Kinase Kinases; Nitrobenzenes; Peptides, Cyclic; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Endothelin; RNA, Messenger; Sulfonamides | 2004 |
Role of prostaglandins in collecting duct-derived endothelin-1 regulation of blood pressure and water excretion.
Topics: Animals; Blood Pressure; Blotting, Western; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; Endothelin-1; Indomethacin; Kidney Medulla; Kidney Tubules, Collecting; Mice; Mice, Knockout; Mice, Transgenic; Nitrobenzenes; Osmolar Concentration; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Renal Agents; Sodium; Sulfonamides; Telemetry; Vasopressins; Water | 2007 |
COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Topics: Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclosporine; Dinoprostone; Endothelin-1; Gene Expression Regulation; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Nitrobenzenes; Primary Cell Culture; Promoter Regions, Genetic; Protein Binding; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Sulfonamides; Transcription, Genetic | 2014 |